Filing Details
- Accession Number:
- 0000950170-24-115031
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-10-16 16:44:00
- Reporting Period:
- 2024-10-14
- Accepted Time:
- 2024-10-16 16:44:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1745999 | Beam Therapeutics Inc. | BEAM | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1786322 | Giuseppe Ciaramella | C/O Beam Therapeutics Inc., 238 Main Street Cambridge MA 02142 | President | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-10-14 | 27,318 | $0.67 | 196,934 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-10-14 | 12,979 | $4.22 | 209,913 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-10-14 | 1,457 | $7.22 | 211,370 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-10-14 | 51,110 | $26.27 | 160,260 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Comon Stock | Stock Option (Right to Buy) | Disposition | 2024-10-14 | 27,318 | $0.00 | 27,318 | $0.67 |
| Comon Stock | Stock Option (Right to Buy) | Disposition | 2024-10-14 | 12,979 | $0.00 | 12,979 | $4.22 |
| Comon Stock | Stock Option (Right to Buy) | Disposition | 2024-10-14 | 1,457 | $0.00 | 1,457 | $7.22 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2024-04-03 | 2028-05-08 | No | 4 | M | Direct |
| 0 | 2024-04-03 | 2029-02-13 | No | 4 | M | Direct |
| 0 | 2029-05-31 | No | 4 | M | Direct |
Footnotes
- The stock option exercises were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 28, 2024.
- The shares of Common Stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 28, 2024.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $26.00 to $26.56, inclusive. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- This stock option vested as to 25% on the first anniversary of the vesting commencement date, October 1, 2019, and at a rate of 2.78% each month thereafter until the option was fully vested.
Billionaire Hedge Funds
